The New York Times, August 21, 2023: After 50 years of repeated failed attempts of discovering respiratory syncytial virus (RSV) vaccine, The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention has approved Pfizer respiratory syncytial virus (RSV) vaccine – ABRYSVO™ for older adults, making […]